The development of bioresorbable composite polymeric implants with high mechanical strength
Source abstract
Abstract
Implants for the treatment of tissue defects should mimic the mechanical properties of the native tissue of interest and should be resorbable as well as biocompatible. In this work, we developed a scaffold from variants of poly(glycolic) acid which were braided and coated with an elastomer of poly(glycolide-co-caprolactone) and crosslinked. The coating of the scaffold with the elastomer led to higher mechanical strength in terms of compression, expansion and elasticity compared to braids without the elastomer coating. These composite scaffolds were found to have expansion properties similar to metallic stents, utilizing materials which are typically much weaker than metal. We optimized the mechanical properties of the implant by tuning the elastomer branching structure, crosslink density, and molecular weight. The scaffolds were shown to be highly resorbable following implantation in a porcine femoral artery. Biocompatibility was studied in vivo in an ovine model by implanting the scaffolds into femoral arteries. The scaffolds were able to support an expanded open lumen over 12 months in vivo and also fully resorbed by 18 months in the ovine model.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Electrospun Nanofibers in Biomedical Applications · Peripheral Artery Disease Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Nishio, S. et al. Long-term (>10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki–Tamai stents. Circulation 125, 2343–2353 (2012).10.1161/CIRCULATIONAHA.110.000901 ↗
2. Bunger, C. M. et al. Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J. Surg. Res. 139, 77–82 (2007).10.1016/j.jss.2006.07.035 ↗
3. Uurto, I. et al. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study. J. Endovasc. Ther. 12, 371–379 (2005).10.1583/05-1525.1 ↗
4. Onuma, Y. et al. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 6, 447–453 (2010).10.4244/EIJ30V6I4A76 ↗
5. Alexy, R. D. & Levi, D. S. Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent. Biomed. Res. Int. 2013, 137958 (2013).10.1155/2013/137985 ↗
6. Scheinert, D. et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J. Am. Coll. Cardiol. 45, 312–315 (2005).10.1016/j.jacc.2004.11.026 ↗
7. van der Giessen, W. J. et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94, 1690–1697 (1996).10.1161/01.CIR.94.7.1690 ↗
8. Lincoff, A. M. et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J. Am. Coll. Cardiol. 29, 808–816 (1997).10.1016/S0735-1097(96)00584-0 ↗
9. Fischell, T. A. Polymer coatings for stents. Can we judge a stent by its cover? Circulation 94, 1494–1495 (1996).10.1161/01.CIR.94.7.1494 ↗
10. Venkatraman, S., Boey, F. & Lao, L. L. Implanted cardiovascular polymers: natural, synthetic and bio-inspired. Prog. Polym. Sci. 33, 853–874 (2008).10.1016/j.progpolymsci.2008.07.001 ↗
11. Vogt, F. et al. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur. Heart J. 25, 1330–1340 (2004).10.1016/j.ehj.2004.06.010 ↗
12. LACTEL Absorbable Polymers. Chemical & Physical Properties of Select Polymers (cited May 26, 2014); http://www.absorbables.com/technical/properties.html
13. Nuutinen, J. P. et al. Mechanical properties and in vitro degradation of bioresorbable knitted stents. J. Biomater. Sci. Polym. Ed. 13, 1313–1323 (2002).10.1163/15685620260449714 ↗
14. Chen, M. C. et al. Rapidly self-expandable polymeric stents with a shape-memory property. Biomacromolecules 8, 2774–2780 (2007).10.1021/bm7004615 ↗
15. Nuutinen, J. P. et al. Mechanical properties and in vitro degradation of bioabsorbable self-expanding braided stents. J. Biomater. Sci. Polym. Ed. 14, 255–266 (2003).10.1163/156856203763572707 ↗
16. Pulapura, S. & Kohn, J. Trends in the development of bioresorbable polymers for medical applications. J. Biomater. Appl. 6, 216–250 (1992).10.1177/088532829200600303 ↗
17. Chen, C. C. et al. Preparation and characterization of biodegradable PLA polymeric blends. Biomaterials 24, 1167–1173 (2003).10.1016/S0142-9612(02)00466-0 ↗
18. Vert, M. et al. Bioresorbability and biocompatibility of aliphatic polyesters. J. Mater. Sci. Mater. Med. 3, 432–446 (1992).10.1007/BF00701240 ↗
19. Orchel, A. et al. Growth of human chondrocytes on biodegradable synthetic polymers. Acta Pol. Pharm. 63, 455–456 (2006).
20. Wise, D. L. Biomaterials and Bioengineering Handbook (CRC Press, 2001).
21. Juan, V. C.-R. et al. Advances in Biomaterials Science and Biomedical Applications Ch. 3: Degradation of Polyurethanes for Cardiovascular Applications (InTech, 2013).
22. Dalene, M., Skarping, G. & Brorson, T. Chromatographic determination of amines in biological fluids with special reference to the biological monitoring of isocyanates and amines. IV. Determination of 1,6-hexamethylenediamine in human urine using capillary gas chromatography and selective ion monitoring. J. Chromatogr. 516, 405–413 (1990).10.1016/S0021-9673(01)89281-5 ↗
23. Dalene, M., Skarping, G. & Tinnerberg, H. Biological monitoring of hexamethylene diisocyanate by determination of 1,6-hexamethylene diamine as the trifluoroethyl chloroformate derivative using capillary gas chromatography with thermoionic and selective-ion monitoring. J. Chromatogr. B. Biomed. Appl. 656, 319–328 (1994).10.1016/0378-4347(94)00137-5 ↗
24. Serruys, P. W. et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 77, 361–371 (1988).10.1161/01.CIR.77.2.361 ↗
25. Leigh Perkins, L. E. Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems. Vet. Pathol. 47, 58–76 (2010).10.1177/0300985809352978 ↗